The present invention relates to antibodies binding IL-15 in particular humanized antibodies. In particular the anti IL-15 antibodies according to the invention are able to neutralize IL-15 activity and are useful in the prevention and/or treatment of an autoimmune disease and/or inflammatory disorder a malignancy transplant rejection metabolic condition and/or an infectious disease caused by parasitic viral or bacterial pathogens.
